Efthymia Papalexi
Memorial Sloan Kettering Cancer Center(US)
Publications by Year
Research Areas
Myeloproliferative Neoplasms: Diagnosis and Treatment, Acute Myeloid Leukemia Research, Epigenetics and DNA Methylation, Cytokine Signaling Pathways and Interactions, Genomics and Chromatin Dynamics
Most-Cited Works
- → Loss of BAP1 function leads to EZH2-dependent transformation(2015)393 cited
- → JAK–STAT Pathway Activation in Malignant and Nonmalignant Cells Contributes to MPN Pathogenesis and Therapeutic Response(2015)306 cited
- → Dual Targeting of Oncogenic Activation and Inflammatory Signaling Increases Therapeutic Efficacy in Myeloproliferative Neoplasms(2017)279 cited
- → Dose-dependent role of the cohesin complex in normal and malignant hematopoiesis(2015)156 cited
- → JAK2/IDH-mutant–driven myeloproliferative neoplasm is sensitive to combined targeted inhibition(2018)77 cited
- → Jak1 Integrates Cytokine Sensing to Regulate Hematopoietic Stem Cell Function and Stress Hematopoiesis(2017)75 cited
- → Tumor-specific HSP90 inhibition as a therapeutic approach in JAK-mutant acute lymphoblastic leukemias(2015)40 cited
- → Reply to "Uveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status"(2016)10 cited
- → JAK1 As a Convergent Regulator of Hematopoietic Stem Cell Function and Stress Hematopoiesis(2016)4 cited
- → Lysine-Specific Histone Demethylase, LSD1, (KDM1A) As a Novel Therapeutic Target in Myeloproliferative Neoplasms(2015)4 cited